| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 183.969 | 83 |
| GSM780708 | Untreated after 4 days (C2_1) | 186.995 | 83 |
| GSM780709 | Untreated after 4 days (C3_1) | 148.036 | 80 |
| GSM780719 | Untreated after 4 days (C1_2) | 213.555 | 84 |
| GSM780720 | Untreated after 4 days (C2_2) | 225.328 | 85 |
| GSM780721 | Untreated after 4 days (C3_2) | 154.92 | 81 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 209.02 | 84 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 201.896 | 84 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 221.161 | 85 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 195.869 | 83 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 211.49 | 84 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 260.355 | 86 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 147.913 | 80 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 199.987 | 84 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 190.243 | 83 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 160.899 | 81 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 196.561 | 83 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 187.753 | 83 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 266.503 | 86 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 239.906 | 85 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 225.279 | 85 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 255.776 | 86 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 215.34 | 84 |